{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T22:21:00Z","timestamp":1767651660371},"reference-count":44,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T00:00:00Z","timestamp":1449014400000},"content-version":"vor","delay-in-days":2618,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Thoracic Oncology"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1097\/jto.0b013e318187464e","type":"journal-article","created":{"date-parts":[[2008,9,24]],"date-time":"2008-09-24T07:12:35Z","timestamp":1222240355000},"page":"1119-1126","source":"Crossref","is-referenced-by-count":21,"title":["Circulating Serum Vascular Endothelial Growth Factor is Not a Prognostic Factor of Non-small Cell Lung Cancer"],"prefix":"10.1016","volume":"3","author":[{"given":"Mohammad","family":"Chakra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean Louis","family":"Pujol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre-Jean","family":"Lamy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie Cecile","family":"Bozonnat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xavier","family":"Quantin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Jacot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Pierre","family":"Daur\u00e8s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1097\/JTO.0b013e318187464e_bib1","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1200\/JCO.1995.13.5.1221","article-title":"Prognostic factors for survival in advanced non-small-cell lung cancer: univariate and multivariate analyses including recursive partitioning and amalgamation algorithms in 1052 patients. The European Lung Cancer Working Party","volume":"13","author":"Paesmans","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0b013e318187464e_bib2","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0169-5002(97)00655-7","article-title":"Prognostic value of histology in patients with non-small cell lung cancer","volume":"17","author":"Charloux","year":"1997","journal-title":"Lung Cancer"},{"key":"10.1097\/JTO.0b013e318187464e_bib3","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1038\/sj.bjc.6601781","article-title":"Do patients with weight loss have a worse outcome when undergoing chemotherapy for lung cancers?","volume":"90","author":"Ross","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1097\/JTO.0b013e318187464e_bib4","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1038\/sj.bjc.6601851","article-title":"CYFRA 21-1 is a prognostic determinant in non-small-cell lung cancer: results of a meta-analysis in 2063 patients","volume":"90","author":"Pujol","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1097\/JTO.0b013e318187464e_bib5","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S1556-0864(15)31609-9","article-title":"Survival differences by sex for patients with advanced non-small cell lung cancer on Eastern Cooperative Oncology Group trial 1594","volume":"1","author":"Wakelee","year":"2006","journal-title":"J Thorac Oncol"},{"key":"10.1097\/JTO.0b013e318187464e_bib6","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1002\/1097-0142(20011115)92:10<2639::AID-CNCR1617>3.0.CO;2-8","article-title":"Outcome of patients with a performance status of 2 in Eastern Cooperative Oncology Group Study E1594: a phase II trial in patients with metastatic non-small cell lung carcinoma","volume":"92","author":"Sweeney","year":"2001","journal-title":"Cancer"},{"key":"10.1097\/JTO.0b013e318187464e_bib7","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1093\/jnci\/89.21.1580","article-title":"Cigarette smoking and changes in the histopathology of lung cancer","volume":"89","author":"Thun","year":"1997","journal-title":"J Natl Cancer Inst"},{"key":"10.1097\/JTO.0b013e318187464e_bib8","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1056\/NEJMc070042","article-title":"Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer","volume":"356","author":"Sandler","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1097\/JTO.0b013e318187464e_bib9","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2007.25.18_suppl.lba7514","article-title":"Randomised, double-blind multicentre phase III study of bevacizumab in combination with cisplatin and gemcitabine in chemotherapy-na\u00efve patients with advanced or recurrent non-squamous non-small cell lung cancer (NSCLC): BO17704","author":"Manegold","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0b013e318187464e_bib10","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.lungcan.2005.05.011","article-title":"Pretreatment vascular endothelial growth factor (VEGF) and matrix metalloproteinase-9 (MMP-9) serum levels in patients with metastatic non-small cell lung cancer (NSCLC)","volume":"50","author":"Laack","year":"2005","journal-title":"Lung Cancer"},{"key":"10.1097\/JTO.0b013e318187464e_bib11","series-title":"Histological Typing of Lung and Pleural Tumors","author":"Travis","year":"1999"},{"key":"10.1097\/JTO.0b013e318187464e_bib12","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0021-9681(60)90137-5","article-title":"Appraisal of methods for the study of chemotherapy of cancer in man: comparative therapeutic trial of nitrogen mustard and triethylene thiophosphoramide","volume":"11","author":"Zubrod","year":"1960","journal-title":"J Chron Dis"},{"key":"10.1097\/JTO.0b013e318187464e_bib13","series-title":"TNM Classification of Malignant Tumours","first-page":"99","article-title":"Lung and pleural tumours","author":"Sobin","year":"2002"},{"key":"10.1097\/JTO.0b013e318187464e_bib14","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002140.pub2","article-title":"Concurrent chemoradiotherapy in non-small cell lung cancer","author":"Rowell","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1097\/JTO.0b013e318187464e_bib15","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1148\/radiology.143.1.7063747","article-title":"The meaning and use of area below the receiver operating characteristic curves","volume":"143","author":"Hanley","year":"1982","journal-title":"Radiology"},{"key":"10.1097\/JTO.0b013e318187464e_bib16","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0169-2607(93)90004-5","article-title":"A computer program for non-parametric receiver operating characteristic analysis","volume":"40","author":"Vida","year":"1993","journal-title":"Comput Methods Programs Biomed"},{"key":"10.1097\/JTO.0b013e318187464e_bib17","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"10.1097\/JTO.0b013e318187464e_bib18","first-page":"201","article-title":"Causes of treatment failure and death in carcinoma of the lung","volume":"54","author":"Cox","year":"1981","journal-title":"Yale J Biol Med"},{"key":"10.1097\/JTO.0b013e318187464e_bib19","doi-asserted-by":"crossref","first-page":"3906","DOI":"10.1200\/JCO.2002.01.033","article-title":"Mechanisms and future directions for angiogenesis-based cancer therapies","volume":"20","author":"Scappaticci","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0b013e318187464e_bib20","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.ejca.2008.03.012","article-title":"The clinical significance of lymphangiogenesis and angiogenesis in non-small cell lung cancer patients","volume":"44","author":"Kadota","year":"2008","journal-title":"Eur J Cancer"},{"key":"10.1097\/JTO.0b013e318187464e_bib21","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1054\/bjoc.1999.1129","article-title":"Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer","volume":"82","author":"O'Byrne","year":"2000","journal-title":"Br J Cancer"},{"key":"10.1097\/JTO.0b013e318187464e_bib22","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/jso.20663","article-title":"Expression of tissue inhibitor of metalloproteinase-3 (TIMP-3) and its prognostic significance in resected non-small cell lung cancer","volume":"95","author":"Mino","year":"2007","journal-title":"J Surg Oncol"},{"key":"10.1097\/JTO.0b013e318187464e_bib23","first-page":"693","article-title":"Increased expression of matrix metalloproteinase-2 (MMP-2) predicts tumour recurrence and unfavourable outcome in non-small cell lung cancer","volume":"23","author":"Leinonen","year":"2008","journal-title":"Histol Histopathol"},{"key":"10.1097\/JTO.0b013e318187464e_bib24","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0169-5002(01)00431-7","article-title":"Expression of membrane-type-1-matrix metalloproteinase and metalloproteinase-2 in non-small cell lung carcinomas","volume":"35","author":"Yamamura","year":"2002","journal-title":"Lung Cancer"},{"key":"10.1097\/JTO.0b013e318187464e_bib25","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1016\/j.ijrobp.2006.04.036","article-title":"Integrin alpha v beta 3 antagonist Cilengitide enhances efficacy of radiotherapy in endothelial cell and non-small-cell lung cancer models","volume":"65","author":"Albert","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1097\/JTO.0b013e318187464e_bib26","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1200\/JCO.2001.19.4.1207","article-title":"Clinical implications of circulating angiogenic factors in cancer patients","volume":"19","author":"Poon","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0b013e318187464e_bib27","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1016\/S0959-8049(98)00282-2","article-title":"Clinical significance of plasma vascular endothelial growth factor in gastrointestinal cancer","volume":"34","author":"Hyodo","year":"1998","journal-title":"Eur J Cancer"},{"key":"10.1097\/JTO.0b013e318187464e_bib28","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1200\/JCO.2001.19.2.577","article-title":"Increased serum concentration of angiogenic factors in malignant melanoma patients correlates with tumor progression and survival","volume":"19","author":"Ugurel","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0b013e318187464e_bib29","doi-asserted-by":"crossref","DOI":"10.1007\/s12032-008-9052-4","article-title":"Prognostic and predictive value of vascular endothelial growth factor and its soluble receptors, VEGFR-1 and VEGFR-2 levels in the sera of small cell lung cancer patients","author":"Ustuner","year":"2008","journal-title":"Med Oncol"},{"key":"10.1097\/JTO.0b013e318187464e_bib30","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0169-5002(01)00200-8","article-title":"Vascular endothelial growth factor in the serum of patients with non-small cell lung cancer: correlation with platelet and leukocyte counts","volume":"33","author":"Choi","year":"2001","journal-title":"Lung Cancer"},{"key":"10.1097\/JTO.0b013e318187464e_bib31","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1093\/annonc\/mdf270","article-title":"Pretreatment serum levels of matrix metalloproteinase-9 and vascular endothelial growth factor in non-small-cell lung cancer","volume":"13","author":"Laack","year":"2002","journal-title":"Ann Oncol"},{"key":"10.1097\/JTO.0b013e318187464e_bib32","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.lungcan.2007.10.006","article-title":"Serum vascular endothelial growth factor is related to systemic oxidative stress in patients with lung cancer","volume":"60","author":"Katsabeki-Katsafli","year":"2008","journal-title":"Lung Cancer"},{"key":"10.1097\/JTO.0b013e318187464e_bib33","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1081\/CNV-200055949","article-title":"Circulating angiogenic cytokines in patients with advanced non-small cell lung cancer: correlation with treatment response and survival","volume":"23","author":"Dudek","year":"2005","journal-title":"Cancer Invest"},{"key":"10.1097\/JTO.0b013e318187464e_bib34","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1177\/172460089400900203","article-title":"Lung cancer-associated keratin 19 fragments: development and biochemical characterisation of the new serum assay Enzymun-Test CYFRA 21-1","volume":"9","author":"Bodenm\u00fcller","year":"1994","journal-title":"Int J Biol Markers"},{"key":"10.1097\/JTO.0b013e318187464e_bib35","first-page":"61","article-title":"Serum fragment of cytokeratin subunit 19 measured by CYFRA 21-1 immunoradiometric assay as a marker of lung cancer","volume":"53","author":"Pujol","year":"1993","journal-title":"Cancer Res"},{"key":"10.1097\/JTO.0b013e318187464e_bib36","first-page":"89","article-title":"Cyfra 21-1, neuron specific enolase and prognosis of non-small cell lung cancer: prospective study in 621 patients","volume":"33","author":"Pujol","year":"2001","journal-title":"Lung Cancer"},{"key":"10.1097\/JTO.0b013e318187464e_bib37","first-page":"28","article-title":"A three-arm trial of vinorelbine (Navelbine) plus cisplatin, vindesine plus cisplatin, and single agent vinorelbine in the treatment of non-small cell lung cancer: an expanded analysis","volume":"21","author":"Le Chevalier","year":"1994","journal-title":"Semin Oncol"},{"key":"10.1097\/JTO.0b013e318187464e_bib38","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1158\/1078-0432.CCR-07-1154","article-title":"Cell adhesion molecules, vascular endothelial growth factor, and basic fibroblast growth factor in patients with non-small cell lung cancer treated with chemotherapy with or without bevacizumab\u2014an Eastern Cooperative Oncology Group Study","volume":"14","author":"Dowlati","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1097\/JTO.0b013e318187464e_bib39","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/sj.bjc.6601987","article-title":"Serum EGF-receptor and HER-2 extracellular domains and prognosis of non-small-cell lung cancer","volume":"91","author":"Jacot","year":"2004","journal-title":"Br J Cancer"},{"issue":"Suppl 2","key":"10.1097\/JTO.0b013e318187464e_bib40","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1016\/S0169-5002(01)00346-4","article-title":"Expression of vascular endothelial growth factor (VEGF) in non-small cell lung cancer (NSCLC): association with p53 gene mutation and prognosis","volume":"34","author":"Nikli\u0144ska","year":"2001","journal-title":"Lung Cancer"},{"key":"10.1097\/JTO.0b013e318187464e_bib41","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0169-5002(01)00195-7","article-title":"Vascular endothelial growth factor and other biological predictors related to the postoperative survival rate on non-small cell lung cancer","volume":"33","author":"Liao","year":"2001","journal-title":"Lung Cancer"},{"key":"10.1097\/JTO.0b013e318187464e_bib42","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1136\/jcp.54.2.116","article-title":"Prognostic value of vascularity and vascular endothelial growth factor expression in non-small cell lung cancer","volume":"54","author":"Baillie","year":"2001","journal-title":"J Clin Pathol"},{"key":"10.1097\/JTO.0b013e318187464e_bib43","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/cncr.11073","article-title":"Clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in patients with non-small cell lung carcinoma","volume":"97","author":"Arinaga","year":"2003","journal-title":"Cancer"},{"key":"10.1097\/JTO.0b013e318187464e_bib44","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1200\/JCO.2005.18.853","article-title":"Angiogenesis and lung cancer: prognostic and therapeutic implications","volume":"23","author":"Herbst","year":"2005","journal-title":"J Clin Oncol"}],"container-title":["Journal of Thoracic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086415320840?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086415320840?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T13:02:41Z","timestamp":1588942961000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1556086415320840"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":44,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["S1556086415320840"],"URL":"https:\/\/doi.org\/10.1097\/jto.0b013e318187464e","relation":{},"ISSN":["1556-0864"],"issn-type":[{"value":"1556-0864","type":"print"}],"subject":[],"published":{"date-parts":[[2008,10]]}}}